Clinical Trials Directory

Trials / Unknown

UnknownNCT03166423

Efficacy and Safety of Snail Slime and Natural Extracts for Healing in Diabetic Foot Ulcers

Clinical Trial Phase I-II of Efficacy and Safety of Snail Slime and Natural Extracts for Healing in Diabetic Foot Ulcers

Status
Unknown
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
90 (estimated)
Sponsor
University of Chile · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The primary objective is to evaluate the efficacy and safety of the use of a formulation of snail slime and natural extracts, for the curative treatment of ulcer wonds in diabetic foot. The secondary objetives: 1. To evaluate the efficacy of the use of a formulation of snail slime Helix aspersa Müller and natural extracts (MU001) for the curative treatment of ulcer wonds in diabetic foot with respect to the standard of care, by means the application of patchs that containing the formulation in a treatment period of until 60 days. 2. To determine the safety of the use of a formulation of snail slime Helix aspersa Müller and natural extracts (MU001) in diabetic individuals in a treatment period of until 60 days.

Detailed description

Clinical Study of phase I-II, controlled, simple blind (in relation with biostatistical analysis), randomized, of formulation that containing snail slime Helix aspersa Müller (Cryptophalus aspersus), natural calendula extract, propolis and excipients (MU001). The formulation in study MU001 wil be added to the standard of care for healing in diabetic foot indicated. The period of recruitment estimated will be 4 month and the follow-up of the patients will be of until 60 days.

Conditions

Interventions

TypeNameDescription
DRUGMU001 patches (Investigational)Patches containing snail slime, calendula extract and propolis extract
DEVICEConventional patches (Control)Patches containing conventional formulations in medical devices for ulcers (hydrocolloids, activated charcoal silver, alginate, carboxymethylcellulose or hydrogel).

Timeline

Start date
2015-11-12
Primary completion
2017-06-01
Completion
2017-07-01
First posted
2017-05-25
Last updated
2017-05-30

Locations

4 sites across 1 country: Chile

Source: ClinicalTrials.gov record NCT03166423. Inclusion in this directory is not an endorsement.